176 related articles for article (PubMed ID: 31567994)
1. Can we cure stage IV triple-negative breast carcinoma?: Another case report of long-term survival (7 years).
Chue BM; La Course BD
Medicine (Baltimore); 2019 Sep; 98(38):e17251. PubMed ID: 31567994
[TBL] [Abstract][Full Text] [Related]
2. Case report of long-term survival with metastatic triple-negative breast carcinoma: Treatment possibilities for metastatic disease.
Chue BM; La Course BD
Medicine (Baltimore); 2019 Apr; 98(16):e15302. PubMed ID: 31008982
[TBL] [Abstract][Full Text] [Related]
3. Clinical activity of adjuvant cytokine-induced killer cell immunotherapy in patients with post-mastectomy triple-negative breast cancer.
Pan K; Guan XX; Li YQ; Zhao JJ; Li JJ; Qiu HJ; Weng DS; Wang QJ; Liu Q; Huang LX; He J; Chen SP; Ke ML; Zeng YX; Xia JC
Clin Cancer Res; 2014 Jun; 20(11):3003-11. PubMed ID: 24668644
[TBL] [Abstract][Full Text] [Related]
4. Where youth matters-clinicopathologic characteristics and emerging trends in treatment and outcomes in young Irish women with breast cancer.
Greally M; Kielty J; Watson GA; Das G; Malouf C; McSorley L; Coleman N; Quinn C; McDermott EW; Gullo G; Crown J; Prichard RS; Kelly CM; Walshe JM
Ir J Med Sci; 2019 Feb; 188(1):59-67. PubMed ID: 29766409
[TBL] [Abstract][Full Text] [Related]
5. [Long-Term Survival of a Patient with Triple-Negative Breast Cancer with Hormone Receptor Status Conversion between Primary and Metastatic Tumors].
Hayashi K; Harao M; Ogihara K; Sasaki Y; Nishida S; Shiba S; Sakuragi M; Kitayama J; Sata N
Gan To Kagaku Ryoho; 2022 Jun; 49(6):697-699. PubMed ID: 35799399
[TBL] [Abstract][Full Text] [Related]
6. Advanced breast cancer with cachexia: A case report.
Liu N; Li S; Jia J; Qiao Y; Li Y
Medicine (Baltimore); 2021 Jan; 100(4):e24397. PubMed ID: 33530236
[TBL] [Abstract][Full Text] [Related]
7. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029
[TBL] [Abstract][Full Text] [Related]
8. Capecitabine metronomic chemotherapy combined with autologous CIK cell immunotherapy in the treatment of recurrent and metastatic triple-negative breast cancer.
Chen S; Yang Y; Jiao Y; Sun H; Yan Z
J BUON; 2021; 26(3):734-740. PubMed ID: 34268928
[TBL] [Abstract][Full Text] [Related]
9. The Role of Postmastectomy Radiotherapy in Locally Advanced Breast Cancer After Pathological Complete Response to Neoadjuvant Chemotherapy.
Flores-Balcázar CH; Castro-Alonso FJ; Hernández-Barragán TP; Delgado-de la Mora J; Daidone A; Trejo-Durán GE
Oncology (Williston Park); 2021 Mar; 35(3):139-143. PubMed ID: 33818049
[TBL] [Abstract][Full Text] [Related]
10. A rare case of secretory breast carcinoma in a male adult with axillary lymph node metastasis.
Ding J; Jiang L; Gan Y; Wu W
Int J Clin Exp Pathol; 2015; 8(3):3322-7. PubMed ID: 26045861
[TBL] [Abstract][Full Text] [Related]
11. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
Curigliano G; Criscitiello C
J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
[TBL] [Abstract][Full Text] [Related]
12. Current and Emerging Therapies for HER2-Positive Women With Metastatic Breast Cancer.
Porter K; Rosenzweig MQ
J Adv Pract Oncol; 2017 Mar; 8(2):164-168. PubMed ID: 29900024
[No Abstract] [Full Text] [Related]
13. Breast Adenoid Cystic Carcinoma: A Rare Case Report and Review of the Literature.
El Amarti L; Raiss H; Layachi M; Baldé S; Ettahri H; Elghissassi I; Mrabti H; Errihani H
Gulf J Oncolog; 2017 May; 1(24):66-69. PubMed ID: 28798006
[TBL] [Abstract][Full Text] [Related]
14. Bilateral Inflammatory Breast Cancer That Developed Two Years after Treatment for Triple-negative Breast Cancer.
Kawaguchi Y; Kuba S; Morita M; Meng X; Hayashi H; Kobayashi K; Adachi T; Hidaka M; Itoh S; Kanetaka K; Eguchi S
Intern Med; 2022 Aug; 61(15):2387-2391. PubMed ID: 35022341
[TBL] [Abstract][Full Text] [Related]
15. A comparison between young and old patients with triple-negative breast cancer: biology, survival and metastatic patterns.
Tzikas AK; Nemes S; Linderholm BK
Breast Cancer Res Treat; 2020 Aug; 182(3):643-654. PubMed ID: 32524352
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel-resistant advanced recurrent breast cancer: a case of partial response due to addition of bevacizumab to paclitaxel therapy: a case report.
Ishizuna K; Ninomiya J; Kojima M; Kawashima M; Nozaki M; Yamagishi H; Ueda Y; Oya M
BMC Res Notes; 2013 Jul; 6():254. PubMed ID: 23830415
[TBL] [Abstract][Full Text] [Related]
17. Long-term complete response in a patient with liver metastases from breast cancer treated with metronomic chemotherapy.
Cecconetto L; Casadei Gardini A; Tenti E; Maltoni R; Bravaccini S; Oboldi D; Zoli W; Serra P; Donati C; Sarti S; Amadori D; Rocca A
Tumori; 2014; 100(3):e79-82. PubMed ID: 25076256
[TBL] [Abstract][Full Text] [Related]
18. [Prolonged remission achieved by using bevacizumab plus paclitaxel therapy combined with sequential radiotherapy for a rapidly growing chest wall recurrence of triple negative breast cancer - a case report].
Kawashima M; Fujii K; Kiso M; Takeyama O; Kan S; Tanaka M
Gan To Kagaku Ryoho; 2015 Jan; 42(1):81-4. PubMed ID: 25596684
[TBL] [Abstract][Full Text] [Related]
19. Prospective comparison of outcome after treatment for triple-negative and non-triple-negative breast cancer.
Joyce DP; Murphy D; Lowery AJ; Curran C; Barry K; Malone C; McLaughlin R; Kerin MJ
Surgeon; 2017 Oct; 15(5):272-277. PubMed ID: 28277293
[TBL] [Abstract][Full Text] [Related]
20. Volume-based parameters of 18F-fluorodeoxyglucose positron emission tomography/computed tomography improve disease recurrence prediction in postmastectomy breast cancer patients with 1 to 3 positive axillary lymph nodes.
Nakajima N; Kataoka M; Sugawara Y; Ochi T; Kiyoto S; Ohsumi S; Mochizuki T
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):738-46. PubMed ID: 24064322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
